![Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic](/i/c/d8ede3e0-46f5-8734-1145-def85ddcf3f4.webp)
Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic
Eli Lilly & Co. won US approval for its diabetes drug to treat obesity, unlocking blockbuster sales potential
2023-11-09 04:27
![Swiss Stocks Are Lagging Eurozone Peers By the Most Since 1999](/i/c/7da76980-c8c2-eb3a-8cb0-797aab9cd82d.webp)
Swiss Stocks Are Lagging Eurozone Peers By the Most Since 1999
Switzerland’s typically staid stock market is headed for its worst annual showing against euro zone peers since 1999,
2023-11-08 15:24
![European Stocks On Track for Best Run Since July on Fed Optimism](/i/c/ffcaf1ed-1d34-f319-4087-2f650fa63472.webp)
European Stocks On Track for Best Run Since July on Fed Optimism
European shares advanced for a fourth day, set for their longest winning streak since July, fueled by hopes
2023-11-02 18:52
![Novo Nordisk’s Earnings Surge on Frenzy for Obesity Drugs](/i/c/e2641487-98cb-2dcb-7056-9c7847d5fec6.webp)
Novo Nordisk’s Earnings Surge on Frenzy for Obesity Drugs
Novo Nordisk A/S sales surged in the third quarter as demand continued unabated for its obesity and diabetes
2023-11-02 16:26
![Novo Nordisk flags continued restrictions on Wegovy supplies](/i/c/c7208d86-673d-ca84-0e9a-bc59e04327c7.webp)
Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
2023-11-02 14:55
![Novartis Lifts Outlook After Shedding Sandoz Generics](/i/c/0bfc4e51-0997-8c1c-83d1-1da276490d8d.webp)
Novartis Lifts Outlook After Shedding Sandoz Generics
Novartis AG raised its profit forecast for a third time in the drugmaker’s first report after spinning off
2023-10-24 15:53
![When Japan Ends Negative Rate Policy, Treasuries Will Suffer](/i/c/2b64e3eb-e334-0898-8586-95aca206545f.webp)
When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
2023-10-23 08:52
![China Weight-Loss Drug Stocks Lose Shine on ‘Misleading’ Claims](/i/c/f158ef2a-3b97-9d04-89b5-0e5e8c41150a.webp)
China Weight-Loss Drug Stocks Lose Shine on ‘Misleading’ Claims
One of the few bright spots in China’s battered equity market is evaporating, with weight-loss drugs plunging after
2023-10-17 14:54
![Novo Nordisk in $1.3 billion deal to buy hypertension drug](/i/c/730a0750-b2a8-701d-b448-eea153fbe2e3.webp)
Novo Nordisk in $1.3 billion deal to buy hypertension drug
COPENHAGEN Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular
2023-10-16 19:23
![A Doctor With Brain Cancer Is Helping Transform Its Treatment](/i/c/de7cb045-5372-3d2e-80bc-938b02819f05.webp)
A Doctor With Brain Cancer Is Helping Transform Its Treatment
When Richard Scolyer was diagnosed with a deadly brain tumor in June, he grasped the test results as
2023-10-14 07:29
![LVMH Sales Growth Slows as Global Luxury Demand Cools](/i/c/595419f0-be59-7190-ac05-361d41e4965a.webp)
LVMH Sales Growth Slows as Global Luxury Demand Cools
LVMH shares fell after the world’s largest luxury group reported softer sales growth in the third quarter —
2023-10-11 15:58
![Novo’s Blockbuster Ozempic Now Shows Kidney Promise, Hitting Rivals](/i/c/986bdf4f-dfab-d62f-4bd1-2c5f763ab239.webp)
Novo’s Blockbuster Ozempic Now Shows Kidney Promise, Hitting Rivals
Novo Nordisk A/S said a kidney failure study of its diabetes drug Ozempic showed effectiveness surprisingly early, sending
2023-10-11 15:47